Tirzepatide activates both GLP-1 and GIP receptors, triggering stronger appetite reduction and metabolic effects than semaglutide monotherapy
Every cycle includes the complete peptide supply, bacteriostatic water, syringes, alcohol swabs, a sharps container, step-by-step instructional videos, a dosing calendar, written protocol guides, provider access during the cycle, and body composition analysis at follow-up visits
Obesity Tirzepatide is often recommended to people who are experiencing obesity and have not been able to achieve significant or sustained weight loss through lifestyle and behavior modifications alone
Key Safety Features Does not significantly elevate cortisol, prolactin, or aldosterone at standard doses the defining advantage over other GHRPs [1]
However, noticeable effects such as reduced appetite, improved blood sugar, or weight loss can take several weeks to become apparent
Medical Citation URL Suran M